GlassScriptPhysician profile
Heather D Grove
NPI 1720030786
$2,284.20
in general payments reported to CMS, 2019-2025
16 companies · $849 in 2025
The $849 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $477 · 2022: $252 · 2023: $269 · 2024: $438 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.71 |
| Education | $182.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $733.46 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $256.66 | 2025 | Dupixent |
| Janssen Biotech, INC. | $237.30 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $223.06 | 2023-2025 | Sotyktu |
| Organogenesis INC. | $193.80 | 2023-2025 | Cygnus Dual, Puraply Wound Matrix, Via Matrix |
| Novartis Pharmaceuticals Corporation | $163.37 | 2023-2025 | |
| Lilly USA, LLC | $146.06 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $137.65 | 2021-2025 | Bimzelx |
| Incyte Corporation | $39.56 | 2023-2024 | Opzelura |
| Pfizer INC. | $36.29 | 2023 | |
| Sun Pharmaceutical Industries INC. | $27.33 | 2021 | |
| Amgen INC. | $23.63 | 2024 | Otezla |
| Convatec INC. | $23.56 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.77 | 2024 | Cyltezo |
| Astrazeneca Pharmaceuticals LP | $14.47 | 2023 | Evusheld |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $13.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Grove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.